Waddell & Associates’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $741K | Sell |
9,474
-41
| -0.4% | -$3.21K | 0.08% | 71 |
|
|
2025
Q1 | $690K | Hold |
9,515
| – | – | 0.08% | 62 |
|
|
2024
Q4 | $704K | Hold |
9,515
| – | – | 0.07% | 67 |
|
|
2024
Q3 | $628K | Buy |
9,515
+80
| +0.8% | +$5.28K | 0.08% | 67 |
|
|
2024
Q2 | $872K | Buy |
9,435
+880
| +10% | +$81.3K | 0.11% | 54 |
|
|
2024
Q1 | $818K | Sell |
8,555
-3,078
| -26% | -$294K | 0.11% | 55 |
|
|
2023
Q4 | $887K | Hold |
11,633
| – | – | 0.12% | 50 |
|
|
2023
Q3 | $806K | Sell |
11,633
-105
| -0.9% | -$7.27K | 0.12% | 58 |
|
|
2023
Q2 | $1.11M | Hold |
11,738
| – | – | 0.16% | 49 |
|
|
2023
Q1 | $971K | Hold |
11,738
| – | – | 0.15% | 50 |
|
|
2022
Q4 | $876K | Hold |
11,738
| – | – | 0.15% | 49 |
|
|
2022
Q3 | $970K | Hold |
11,738
| – | – | 0.19% | 41 |
|
|
2022
Q2 | $1.12M | Buy |
11,738
+23
| +0.2% | +$2.19K | 0.23% | 39 |
|
|
2022
Q1 | $1.38M | Buy |
11,715
+2,400
| +26% | +$283K | 0.22% | 33 |
|
|
2021
Q4 | $1.21M | Hold |
9,315
| – | – | 0.19% | 35 |
|
|
2021
Q3 | $1.06M | Hold |
9,315
| – | – | 0.18% | 39 |
|
|
2021
Q2 | $965 | Buy |
+9,315
| New | +$965 | 0.15% | 36 |
|